Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapy

Research output: Contribution to journalArticleAcademicpeer-review

12 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Successful switch to rilpivirine/tenofovir/emtricitabine in HIV-1-infected patients with an isolated K103N mutation acquired during prior nonnucleoside reverse transcriptase inhibitor therapy'. Together they form a unique fingerprint.

Medicine and Dentistry